ImmuneOnco Sets 2026 AGM to Approve Results, Profit Plan and Share Issuance Mandate

TipRanksApr 30 17:16

IMMUNEONCO-B: Annual Report 2025

HKEXApr 29 06:11 · Announcements

Immunotech Biopharmaceuticals has risen, with its subsidiary Immunocare completing the enrollment of all subjects for the MAD study of the IMC-003 project.

IMMUNOON-B (01541) once surged over 5%. As of the time of writing, it has risen by 5.29%, trading at HKD 5.77, with a turnover of HKD 8.9842 million.

Zhitong FinanceApr 22 14:47

Hong Kong Stock Market Midday Review | Hang Seng Index fell 1.18% in the morning session, while storage-related concept stocks performed strongly against the market trend.

51 Vision (06651) surged over 11% after the company recently unveiled the world's first 'physical intuition' world model.

Zhitong FinanceApr 13 12:00

Stock Movement in Hong Kong | Yiming Angke-B (01541) Surges Over 17% as CD47 Bispecific Antibody Clinical Value is Supported by Science Magazine

Yimeng Angke-B (01541) surged over 17%. As of the time of writing, it had risen by 17.09%, trading at HKD 5.55, with a turnover of HKD 11.4379 million.

Zhitong FinanceApr 13 10:21

Trump takes action on pharmaceuticals! Import drugs face a maximum tax rate of 100%.

Trump fulfilled his threat by imposing a tariff of up to 100% on certain imported patented drugs. However, giants such as Merck and Eli Lilly and Co had already privately 'negotiated for exemptions.' Who will ultimately bear the brunt?

Golden10 DataApr 3 07:59